ERIS LIFESCIENCES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 908 INR | +2.42% |
|
+3.65% | -0.23% |
| 05-21 | Eris Lifesciences Gets Board Nod to Raise Up to INR12.50 Billion Via Bond Sale | MT |
| 04-03 | Eris Lifesciences Completes Acquisition of Biocon Biologics' India Formulation Business | MT |
Chart calendar Eris Lifesciences Limited
2f28994.BqocNyxxFLskFYO9HK2fjt_8T6dFifvM6KxooBXjoa8.XppwdhQSIdp7cPHUdOj9x_KvH9YdsaOW0NYRw3aW4N92xnRDRBd48l184A~90a98dc6fa8708762c6fe598ecd2fd3a
Upcoming events on Eris Lifesciences Limited
Past events on Eris Lifesciences Limited
| 2024-05-21 07:00 | Q4 2024 Earnings Call |
| 2024-05-20 | Q4 2024 Earnings Release |
| 2024-05-06 | Investor Meeting - TT International |
| 2024-04-02 | Investor Meeting - Tata AIA Life Insurance |
| 2024-03-20 | Investor Meeting - Steinberg India Advisors |
| 2024-03-14 07:00 | Business Update Call |
| 2024-02-29 | Investec Promoter & Founder Conference |
| 2024-02-20 | Investor Meeting |
| 2024-02-15 | IIFL Enterprising India Global Investors Conference |
| 2024-02-14 | Axis Capital India Conference |
| 2024-02-13 06:00 | Q3 2024 Earnings Call |
| 2024-02-13 05:05 | Q3 2024 Earnings Release |
| 2024-01-29 | Investor Meeting - SBI Life Insurance Co Ltd |
| 2024-01-18 | Investor Meeting |
| 2024-01-17 | Investor Meeting - Franklin Templeton |
| 2024-01-16 | Investor Meeting - HBM Healthcare Investments |
| 2024-01-08 | Investor Meeting - Grandeur Peak Global |
| 2023-12-10 | Investor Meeting - Ambit Capital Private Limited |
| 2023-11-29 | Investor Meeting - Ellipsis Partners |
| 2023-11-08 06:30 | Q2 2024 Earnings Call |
Past dividends on Eris Lifesciences Limited
| 2022-08-10 | Interim Payment 7.35 INR |
| 2021-08-04 | Interim Payment 6.01 INR |
| 2020-08-12 | Interim Payment 5.5 INR |
| 2020-03-18 | Interim Payment 2.87 INR |
Annual results
| Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 9 822 10 297 -4.62% | 10 741 10 546 1.84% | 12 119 12 080 0.32% | 13 470 13 411 0.45% | 16 851 16 921 -0.41% | 20 091 19 696 2.01% |
|
EBITDA Million INR | Released Forecast Spread | 3 449 3 818 -9.66% | 3 683 3 593 2.49% | 4 306 4 165 3.38% | 4 850 4 881 -0.64% | 5 367 5 475 -1.96% | 6 748 7 092 -4.85% |
|
EBIT Million INR | Released Forecast Spread | 3 086 3 479 -11.3% | 3 180 3 072 3.5% | 3 876 3 585 8.1% | 4 203 4 265 -1.48% | 4 197 4 375 -4.08% | 4 922 5 314 -7.38% |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 3 174 3 454 -8.12% | 3 315 3 297 0.54% | 3 945 3 814 3.43% | 4 422 4 464 -0.95% | 4 046 4 237 -4.5% | 4 312 4 684 -7.94% |
|
Net income Million INR | Released Forecast Spread | 2 908 3 180 -8.54% | 2 963 2 960 0.1% | 3 551 3 557 -0.15% | 4 061 4 060 0.04% | 3 822 3 934 -2.86% | 3 920 4 101 -4.42% |
|
EPS INR | Released Forecast Spread | 21,1 22,8 -7.32% | 21,6 21,4 0.79% | 26,1 26,1 0.34% | 29,9 29,6 0.86% | 28,1 28,7 -2.11% | 28,8 30,1 -4.26% |
| Announcement Date | 21/05/19 | 02/06/20 | 13/05/21 | 03/05/22 | 17/05/23 | 21/05/24 |
Quarterly results
| Fiscal Period | Maart | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 2 782 2 856 -2.6% | 3 437 3 421 0.47% | 3 597 3 640 -1.2% | 3 322 3 362 -1.19% | 3 059 3 022 1.24% | 3 986 3 855 3.41% | 4 605 4 483 2.73% | 4 233 4 324 -2.11% | 4 028 4 009 0.49% | 4 666 4 720 -1.13% | 5 094 | 4 825 | 5 131 |
|
EBITDA Million INR | Released Forecast Spread | 945 924 2.35% | 1 265 1 227 3.13% | 1 398 1 355 3.21% | 1 217 1 188 2.46% | 969 1 044 -7.21% | 1 292 1 238 4.34% | 1 514 1 446 4.72% | 1 372 1 420 -3.4% | 1 189 1 245 -4.5% | 1 697 1 614 5.18% | 1 819 | 1 740 | 1 788 |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 847 934 -9.28% | 1 171 1 134 3.26% | 1 308 1 285 1.78% | 1 090 1 134 -3.86% | 853 925 -7.74% | 1 013 1 104 -8.23% | 1 209 1 166 3.76% | 1 065 1 087 -1.99% | 759 772 -1.68% | 1 125 1 068 5.35% | 1 288 | 1 195 | 1 102 |
|
Net income Million INR | Released Forecast Spread | 682 786 -13.13% | 1 067 1 074 -0.72% | 1 184 1 173 0.93% | 1 008 1 010 -0.23% | 803 845 -5.02% | 946 1 002 -5.6% | 1 203 1 074 12.06% | 1 019 1 010 0.82% | 654 613 6.8% | 949 930 1.97% | 1 088 | 1 022 | 912 |
|
EPS INR | Released Forecast Spread | 7,88 | 6,60 | |||||||||||
| Announcement Date | 13/05/21 | 29/07/21 | 29/10/21 | 28/01/22 | 03/05/22 | 05/08/22 | 20/10/22 | 17/01/23 | 17/05/23 | 07/08/23 | - | - | - |
More events
Past sector events for Eris Lifesciences Limited
| Today | GLAND PHARMA LIMITED: Q4 2024 Earnings Release |
| 2024-05-20 | ERIS LIFESCIENCES LIMITED: Q4 2024 Earnings Release |
| 2024-05-20 17:00 | TARO PHARMACEUTICAL INDUSTRIES LTD.: Q4 2024 Earnings Release |
| 2024-05-17 08:52 | J. B. CHEMICALS & PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 2024-05-17 04:28 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 2024-05-15 10:05 | MANKIND PHARMA LIMITED: Q4 2024 Earnings Release |
| 2024-05-15 01:30 | DERMAPHARM HOLDING SE: Q1 2024 Earnings Release |
| 2024-05-15 07:40 | CRESCO LABS INC.: Q1 2024 Earnings Release |
| 2024-05-15 03:03 | GRANULES INDIA LIMITED: Q4 2024 Earnings Release |
| 2024-05-14 | EISAI CO., LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ERIS Stock
- Calendar Eris Lifesciences Limited
